Asthma is a long-standing inflammatory disorder of the airways, marked by recurrent episodes of wheezing, coughing, and breathlessness that can vary in severity. These symptoms stem from airway narrowing, mucus buildup, and hyperresponsiveness to triggers such as allergens, smoke, or infections. The condition affects both children and adults, often influenced by hereditary factors and environmental exposures. Diagnosis requires careful evaluation through spirometry, peak flow monitoring, and assessment of how symptoms respond to inhaled medications. Recognizing disease patterns at an early stage is crucial to prevent worsening airflow limitation and frequent flare-ups.
In managing this condition, treatment plans emphasize not only pharmacologic options but also lifestyle and educational strategies that help individuals remain in control of their symptoms. The role of asthma management has grown to encompass inhaled corticosteroids and long-acting bronchodilators as well as advanced biologic therapies for severe cases. Beyond drug therapy, attention is given to allergen reduction, physical fitness, smoking cessation, and improved indoor air quality. Patient training on correct inhaler technique, adherence to prescribed regimens, and use of personalized action plans ensures more stable outcomes. Ongoing follow-up visits, pulmonary rehabilitation, and the use of digital health technologies support long-term control. With this integrated approach, patients experience fewer hospitalizations, greater participation in daily activities, and an overall improvement in respiratory well-being.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation